Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ What Does Endava plc′s 24.37% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith... (PR Newswire) +++ ENDAVA Aktie +3,97%

SAMSUNG VZ Aktie

 >SAMSUNG VZ Aktienkurs 
2940 EUR    +2.1%    (TradegateBSX)
Ask: 2940 EUR / 10 Stück
Bid: 2890 EUR / 10 Stück
Tagesumsatz: 597 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
SAMSUNG VZ Aktie über LYNX handeln
>SAMSUNG VZ Performance
1 Woche: +2,7%
1 Monat: -13,4%
3 Monate: +10,3%
6 Monate: +24,1%
1 Jahr: +127,1%
laufendes Jahr: +120,5%
>SAMSUNG VZ Aktie
Name:  SAMSUNG ELECTRONICS VZ GDR
Land:  USA
ISIN/ Wkn:  US7960502018 / 881823
Symbol/ Ticker:  SSUN (Frankfurt)
Kürzel:  FRA:SSUN, ETR:SSUN, SSUN:GR
Index:  -
Profil:  Samsung Electronics Co., Ltd. GDR (Preferred Stock) represents non-voting preferred shares of Samsung Electronics, packaged into a global depositary receipt format for trading in international markets. The underlying company is a major South Korean t..
>Volltext..
Marktkapitalisierung:  953399.71 Mio. EUR
Unternehmenswert:  953399.71 Mio. EUR
Umsatz:  365769.34 Mio. EUR
EBITDA:  -
Nettogewinn:  130792.49 Mio. EUR
Gewinn je Aktie:  494.62 EUR
Schulden:  -
Liquide Mittel:  -
Operativer Cashflow:  -
Bargeldquote:  -
Umsatzwachstum:  81.93%
Gewinnwachstum:  530.03%
Dividende je Aktie:  19.33 EUR
Dividendenrendite:  0.66%
Dividendenschätzung:  0.77%
Div. Historie:  29.06.26 - 5.854003€
30.03.26 - 5.3147078€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  SAMSUNG VZ, SAMSUNG, SAMSUNGS
Letzte Datenerhebung:  03.11.26
>SAMSUNG VZ Kennzahlen
Aktien/ Unternehmen:
Aktien: 32.09 Mio. St.
Frei handelbar: -
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 128881
Umsatz/Mitarb.: 1.63 Mio. EUR
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: -
KBV: -
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: 35.76%
Operative Marge: 46.14%
Managementeffizenz:
Gesamtkaprendite: -
Eigenkaprendite: -
>SAMSUNG VZ Peer Group
 
03.11.26 - 15:18
Teva to buy U.S. rights to two Samsung Bioepis biosimilars (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.11.26 - 14:27
Samsung to make chip parts for AMD, Nvidia at Texas plant: report (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
03.11.26 - 11:54
Teva To Obtain U.S. Commercialization Rights For Two FDA-approved Immunology Biosimilars (AFX)
 
PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries (TEVA) and Samsung Bioepis have entered into a license and commercialization agreement for two FDA-approved immunology biosimilars: inflixima......
03.11.26 - 11:06
Samsung reportedly plans Galaxy-style TV lineup for 2027 (Digitimes)
 
Samsung Electronics is considering a major overhaul of its TV lineup for 2027, replacing technology-based product names with three tiers modeled on its Galaxy smartphones as it looks to increase shipments and expand its services business, South Korea's ETNews reported....
03.11.26 - 11:06
Apple′s iPhone Duo launch lifts Samsung Galaxy Z Fold 8 sales in South Korea (Digitimes)
 
Samsung Electronics' Galaxy Z Fold 8 weekly sales in South Korea increased by more than 20% in the week after Apple launched its first foldable iPhone Duo, according to Seoul Economic Daily and Financial News. The increase followed the iPhone Duo's South Korean debut on October 23, 2026, as reported problems involving shipment delays and cracked internal displays created additional attention for Samsung's competing foldable device....
03.11.26 - 11:01
Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S. (GlobeNewswire EN)
 
Teva and Samsung Bioepis agree to commercialize two FDA-approved immunology biosimilars in the U.S., expanding Teva's biosimilars portfolio...
03.11.26 - 05:06
Samsung to exit 8-inch foundry business by 2030, report says (Digitimes)
 
Samsung Electronics plans to shut down its remaining 8-inch foundry lines by the end of 2030, forcing South Korean chip designers to seek alternative manufacturing capacity as competing foundries operate near full capacity, The Elec reported....
03.11.26 - 04:06
Nvidia strengthens South Korea ties at AI Day Seoul (Digitimes)
 
Nvidia will showcase its expanding partnerships with South Korean companies at AI Day Seoul, where Samsung Electronics and SK Hynix will present semiconductor development cases using Nvidia AI technologies. LG Electronics and Doosan Robotics will demonstrate robotics technologies, while SK Telecom (SKT), Naver Cloud, and Coupang will discuss the development and operation of AI data centers and infrastructure....
03.11.26 - 04:06
Micron dismisses 4F-squared DRAM as CXMT presses ahead — why Samsung, SK Hynix remain divided (Digitimes)
 
Micron Technology and China's CXMT have taken sharply different approaches to next-generation DRAM scaling, exposing a divide over the commercial viability of 4F-squared memory-cell architecture. While CXMT is advancing 4F-squared towards commercial production to improve bit density, Micron argues that capacitor-scaling constraints undermine its cost advantages and is prioritising 6F-squared technology and a longer-term transition to 3D DRAM. Samsung Electronics and SK Hynix, meanwhile, are pursuing alternative development paths, highlighting the industry's competing approaches to extending DRAM density and manufacturing efficiency....
03.11.26 - 03:06
Samsung′s Young Hyun Jun urges humility, customer trust amid semiconductor profit boom (Digitimes)
 
Despite record profits driven by surging demand for artificial intelligence (AI) and a booming semiconductor industry, Samsung Electronics vice chairman and head of its Device Solutions (DS) division Young Hyun Jun said the company's technological competitiveness has yet to fully recover. He urged employees to strengthen next-generation technologies, quality, and yields, and maintain customer trust during the industry boom while building long-term competitiveness capable of adapting to market changes....
03.11.26 - 00:42
Samsung reportedly in talks with Nidec to develop robot motors (Digitimes)
 
Samsung Electronics is reportedly in talks with Japanese motor maker Nidec to jointly develop robot motors as the South Korean company expands its humanoid robotics business and pushes to automate its factories....
03.11.26 - 00:42
Samsung Electro-Mechanics starts mass production of ADAS MLCCs (Digitimes)
 
Samsung Electro-Mechanics (Semco) has begun mass production of a miniature, ultra-high-capacitance multilayer ceramic capacitor (MLCC) for advanced driver assistance systems (ADAS), as increasingly powerful automotive processors drive demand for smaller components capable of maintaining stable power supplies....
02.11.26 - 10:01
Tesla und Samsung warnen vor Trumps Vietnam-Zöllen (Ariva)
 
Tesla und Samsung stellen sich gegen die Zollpläne von US-Präsident Donald Trump. Beide Konzerne warnen vor erheblichen Folgen für ihre Produktion und Lieferketten. Der Handelskonflikt zwischen den USA und Vietnam spitzt sich zu. Während die Regierung von US-Präsident Donald Trump weitere Strafzölle gegen das südostasiatische Land prüft, schlagen zwei der weltweit größten Technologiekonzerne Alarm. Der Elektroautobauer Tesla ......
02.11.26 - 07:36
Samsung hält nach Ablauf der Nachfrist fast 98 Prozent der Polypeptide-Aktien (Cash)
 
Übernahme - Samsung Biologics hält nun 97,99 Prozent am Pharmazulieferer Polypeptide....
02.11.26 - 07:09
Ad-hoc News: Polypeptide Group AG (EQS)
 
PolyPeptide Group: Provisional end result of the public tender offer of Samsung Biologics Co., Ltd....
02.11.26 - 07:06
South Korea builds SMR ecosystem as SK Innovation advances Natrium tech, Samsung C&T pushes modular construction (Digitimes)
 
South Korean energy and engineering companies are positioning themselves for the emerging small modular reactor (SMR) market, with SK Innovation (SKI) seeking to build expertise through US demonstration and early commercial projects before pursuing domestic deployment, while Samsung C&T is focusing on modular construction to shorten project timelines, reduce costs, and accelerate commercialization....
02.11.26 - 07:06
Samsung to buy TCL CSOT stake from its own display unit for US$960 million (Digitimes)
 
Samsung Electronics plans to acquire Samsung Display's entire 10.16% stake in China's TCL CSOT for KRW1.2718 trillion (approx. US$960 million), moving the investment from its OLED-focused subsidiary to the parent company, whose TV business continues to rely on Chinese LCD panel suppliers....
02.11.26 - 06:24
Tesla, Samsung flag manufacturing risks from Trump′s Vietnam tariff push (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.11.26 - 05:48
Samsung chairman Lee Jae-yong turns to Japan for AI chip packaging edge (Digitimes)
 
Samsung Electronics chairman Lee Jae-yong visited the company's Advanced Package Lab (APL) in Yokohama, Japan, on November 1, as the chipmaker looks to Japan's semiconductor materials and equipment industry to strengthen its advanced packaging capabilities for AI processors....
02.11.26 - 05:48
Samsung partners with PXPay to bolster Samsung Wallet in Taiwan (Digitimes)
 
Samsung Electronics Taiwan is partnering with local mobile payment platform PXPay as part of its expansion of Samsung Wallet applications. The move, announced on October 30 with services beginning on November 1, follows the earlier integration of tap-and-pay EasyCard functions into Samsung Wallet and aims to strengthen Samsung's competitiveness in Taiwan's mobile payment market. It forms part of a key strategy focused on the value of the company's proprietary applications as surging memory prices continue to impact smartphone sales numbers....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Bock ist ein Tier, welches auch als Bier getrunken werden kann. - Wilhelm Busch
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!